GRDN
Guardian Pharmacy Services, Inc.NYSEHealthcare$37.99+0.98%ClosedMarket Cap: $2.41B
As of 2026-04-06
Valuation
P/E (TTM)
48.89
PEG
0.31
P/B
11.83
P/S
1.68
EV/EBITDA
23.50
DCF Value
$14.49
FCF Yield
3.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
19.5%
Operating Margin
6.1%
Net Margin
3.4%
ROE
27.5%
ROA
11.9%
ROIC
22.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $397.6M | 18.8% | $47.0M | $20.9M | $0.33 | — |
| FY 2025 | $1.45B | 19.5% | $88.9M | $49.2M | $0.78 | — |
| Q3 2025 | $377.4M | 19.8% | $16.4M | $9.8M | $0.15 | — |
| Q2 2025 | $344.3M | 19.8% | $12.6M | $9.0M | $0.14 | — |
| Q1 2025 | $329.3M | 19.5% | $13.0M | $9.4M | $0.15 | — |
| Q4 2024 | $338.6M | 19.8% | $16.8M | $11.9M | $0.20 | — |
| FY 2024 | $1.23B | 19.9% | $-62.9M | $-87.3M | $-1.77 | — |
| Q3 2024 | $314.4M | 19.4% | $-104.6M | $-112.6M | $-2.00 | — |
| Q2 2024 | $300.0M | 20.4% | $17.0M | $10.6M | $0.17 | — |
| Q1 2024 | $275.4M | 20.0% | $7.9M | $2.8M | $-0.14 | — |
| Q4 2023 | $281.1M | 19.4% | $15.5M | $12.0M | $0.38 | — |
| FY 2023 | $1.05B | 19.9% | $40.9M | $23.9M | $0.39 | — |